Raffi Asadorian is the current CFO at Acelrx Pharmaceuticals. Raffi has previously served as the CFO for Amyris from January 2015 to January 2017, Unilabs from August 2009 to October 2014, and Barr Pharmaceuticals from November 2007 to August 2009. Prior to their career in pharmaceuticals, Asadorian was a partner at PricewaterhouseCoopers from September 1991 to November 2007.
Raffi Asadorian has an MBA in finance from Alliance Manchester Business School and a degree from Xavier University.
Raffi Asadorian works with Pamela P. Palmer - Chief Medical Officer and Co-Founder, Badri Dasu - Chief Engineering Officer, and Larry G. Hamel - Chief Development Officer. Raffi Asadorian reports to Vincent J. Angotti, CEO.
Sign up to view 0 direct reports
Get started